Unbound MEDLINE

Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. [Catheter Cardiovasc Interv] Journal article

 
Reddy MS, Carmody TJ, Kereiakes DJ 
Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy. [Case Reports, Journal Article]
Catheter Cardiovasc Interv 2001 Apr; 52(4):486-8.


Acute thrombocytopenia associated with abciximab therapy has been well described, although the exact mechanism remains obscure. We report a case of delayed severe thrombocytopenia associated with abciximab therapy for percutaneous coronary intervention that occurred following hospital discharge. The detection of this phenomenon is important as it may portend heightened risk for severe or profound thrombocytopenia on subsequent reexposure to abciximab therapy.



More from this journalRelated subjects (MeSH)
  
Advertise on this site.